Mass Spectrometry Imaging of Neurotransmitters

2020 ◽  
Author(s):  
Katherine A. Stumpo

Mass spectrometry imaging (MSI) is a powerful analytical method for the simultaneous analysis of hundreds of compounds within a biological sample. Despite the broad applicability of this technique, there is a critical need for advancements in methods for small molecule detection. Some molecular classes of small molecules are more difficult than others to ionize, e.g., neurotransmitters (NTs). The chemical structure of NTs (i.e., primary, secondary, and tertiary amines) affects ionization and has been a noted difficulty in the literature. In order to achieve detection of NTs using MSI, strategies must focus on either changing the chemistry of target molecules to aid in detection or focus on new methods of ionization. Additionally, even with new strategies, the issues of delocalization, chemical background noise, and ability to achieve high throughput (HTP) must be considered. This chapter will explore previous and up-and-coming techniques for maximizing the detection of NTs.


2020 ◽  
Vol 590 ◽  
pp. 119949 ◽  
Author(s):  
Anne Mette Handler ◽  
Mariam Fallah ◽  
Anders Just Pedersen ◽  
Gitte Pommergaard Pedersen ◽  
Kim Troensegaard Nielsen ◽  
...  


2019 ◽  
Vol 26 (4) ◽  
pp. 794-802 ◽  
Author(s):  
Pan Shu ◽  
Ting Zhao ◽  
Bo Wen ◽  
Kari Mendelsohn-Victor ◽  
Duxin Sun ◽  
...  

Objectives Despite safe handling guidelines published by several groups, health care worker exposure to hazardous drugs continues to occur due to suboptimal engineering controls and low use of protective equipment. Simple, multi-target and specific analytical methods are needed so that acute exposures to these drugs in the workplace can be assessed rapidly. Our aim was to develop an analytical method for simultaneous detection and quantification of widely used cancer drugs to rule out accidental acute chemotherapy exposures in health care workers. Methods We examined the feasibility of alternate high-performance liquid chromatographic-tandem mass spectrometry methods to simultaneously detect eighteen chemotherapy analytes in plasma and urine. The linear concentration ranges tested during assay development were 0.1–50 ng/mL. After development of a multi-analyte assay protocol, plasma samples (n = 743) from a multi-center cluster-randomized clinical trial (n = 12 sites) of an hazardous drug educational intervention were assayed. Confirmatory assays were performed based on the individual acute-spill case-histories. Results An innovative HPLC-multiple reaction monitoring-information dependent acquisition-enhanced production ion (MRM-IDA-EPI) analytical method was developed to simultaneously detect: cytarabine, gemcitabine, dacarbazine, methotrexate, topotecan, mitomycin, pemetrexed, irinotecan, doxorubicin, vincristine, vinblastine, ifosamide, cyclophosphamide, vinorelbine, bendamustine, etoposide, docetaxel, and paclitaxel. The retention times ranged from 4 min to 13 min for the analytical run. The limit of detection (MRM-IDA-EPI) and limit of quantitation (MRM) was 0.25 ng/mL and 0.1 ng/mL, respectively for most analytes. No detectable plasma concentrations were measured at baseline, post-intervention and in cases of documented acute spills. Use of a secondary tandem mass spectrometry approach was able to successfully rule out false positive results. Conclusions Development of a sensitive high-throughput multi-analyte cancer chemotherapy assay is feasible using an MRM-IDA-EPI method. This method can be used to rapidly rule out systemic exposure to accidental acute chemotherapy spills in health care workers.



2016 ◽  
Vol 30 (15) ◽  
pp. 1787-1796 ◽  
Author(s):  
Andrew D. Wagner ◽  
Lisa Elkin ◽  
Kathy Mosure ◽  
Lizbeth Gallagher ◽  
Lindsey K. Stavola ◽  
...  


2015 ◽  
Vol 31 ◽  
pp. 1-9 ◽  
Author(s):  
Tristan de Rond ◽  
Megan Danielewicz ◽  
Trent Northen


Author(s):  
Xuerong Chen ◽  
Tony Y Hu

Abstract Diagnosis of tuberculosis can be difficult as advances in molecular diagnosis approaches (especially nanoparticles combined with high-throughput mass spectrometry for detecting mycobacteria peptide) and personalized medicine result in many changes to the diagnostic framework. This review will address issues concerning novel technologies from bench to bed and new strategies for personalized tuberculosis diagnosis.



Author(s):  
Jun-Young Yang ◽  
Hyun-Kyong Ahn ◽  
Si-Won Lee ◽  
You-Jung Han ◽  
Young-Jun Oh ◽  
...  

AbstractSince the urinary concentration of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) is a reliable biomarker of exposure to tobacco smoke, we developed a relatively simple high-throughput chromatographic method to quantify total urinary NNAL concentrations in the general population.The high-throughput analytical method was developed using ultra-performance liquid chromatography coupled with tandem mass spectrometry (UPLC-MS/MS) to identify and quantify total urinary NNAL concentrations in 10 non-smokers and 15 otherwise healthy smokers.Loss of nitric oxide atAn UPLC-MS/MS analytical method to quantify total urinary NNAL concentrations in smokers that does not require sample derivatization is presented herein. The method could be useful in clarifying the toxicities associated with human exposure to cigarette smoking. However, quantification might be adversely affected by co-eluting interfering compounds or selective ion suppression or enhancement as a result of having only one ion transition to monitor NNAL and NNAL-methyl-



RSC Advances ◽  
2015 ◽  
Vol 5 (96) ◽  
pp. 78728-78737 ◽  
Author(s):  
Yang Wang ◽  
Shuying Liu ◽  
Yuanjia Hu ◽  
Peng Li ◽  
Jian-Bo Wan

Metabolomics aims at the comprehensive assessment of a wide range of endogenous metabolites and attempts to identify and quantify the attractive metabolites in a given biological sample.



2019 ◽  
Vol 12 ◽  
pp. 7-15 ◽  
Author(s):  
Lennart R.S. Huizing ◽  
Shane R. Ellis ◽  
Bart W.A.M.M. Beulen ◽  
Florian P.Y. Barré ◽  
Paul B. Kwant ◽  
...  




Sign in / Sign up

Export Citation Format

Share Document